Findings for Srebp1c mRNA expression as well as PPARγ activity and expression in liver are somewhat contrasting the findings of others reporting that in settings of high-fat diet/ obesity-associated NAFLD, these nuclear factors are found to be increased [50–52]. Here, SREBF1 is linked to metabolic dysfunction-associated steatotic liver disease.